Background The correlation between early pregnancy loss and maternal age is well-
documented. As maternal age increases, anti-Mullerian hormone (AMH), a biomarker of …

Objective Serum antimullerian hormone (AMH) levels are routinely used to predict an
individual patient's response to controlled ovarian stimulation [1]. It is controversial, however …

BACKGROUND To determine whether women with extremely low-serum anti-Mullerian
hormone (AMH) levels (< 0.1–0.4 ng/ml) still demonstrate live birth potential with assisted …

Background Anti-Müllerian hormone (AMH) is used as a biomarker to estimate ovarian
reserve. The relationship between AMH and early miscarriage of in vitro fertilization (IVF) is …

Abstract Anti-Mullerian Hormone (AMH) is considered to be one of the most relevant
markers of ovarian reserve. However, its association with oocyte quality, pregnancy …

Research question Is blood anti-Müllerian hormone (AMH) concentration a strong
determinant of unexplained recurrent early miscarriage (REM)? Design In the first part of the …

Background Ovarian reserve testing is not routinely performed in the evaluation of recurrent
pregnancy loss (RPL). The objective of this study was to determine if AMH levels are …

Background The number of unintentionally childless couples is increasing as more couples
seek to conceive for the first time in the third or fourth decade of the woman's life …

STUDY QUESTION Is a low (< 1.0 μg/L) or moderately low (1.0–1.9 μg/L) serum anti-
Müllerian hormone (AMH) level a risk factor for early pregnancy loss in IVF/ICSI with a fresh …

Objective To assess whether ethnic differences in serum anti‐Mullerian hormone (AMH)
exist in a population of subfertile women presenting to a fertility clinic. Design Observational …